Medication info
Glymet 2/500 mg Tablets

Glymet 2/500 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
White, rectangular, film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201107221 · Approved 2011.09.27 · Insurance code 669905520

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to help blood sugar control in patients with type 2 diabetes. The active ingredients glymeperide and metformin work together to effectively lower blood sugar levels. It is primarily administered as an adjunct to dietary and exercise therapy for patients. This helps maintain stable blood sugar levels and aids in the prevention of complications. It plays an important role in healthy blood sugar management, so it is advisable to take it regularly. This medication improves blood sugar control.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted taking into account the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, with doses up to glimepiride/metformin hydrochloride 8mg/2000mg having been administered. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia, so treatment should be temporarily suspended if there is a rapid decline in kidney function or symptoms of dehydration. It should not be administered to patients with a kidney function of less than 45 mL/min/1.73 m², and caution is warranted when used with medications that may worsen kidney function. Patients with cardiovascular disease or a history of myocardial infarction should use this medication cautiously due to an increased risk of cardiovascular mortality. It should not be used in pregnant women or women who may become pregnant, nursing mothers, patients with severe liver dysfunction, or severe kidney dysfunction. Patients at high risk for hypoglycemia, those in a state of malnutrition, those with irregular food intake, and those performing intense exercise should closely monitor their blood sugar from the beginning of treatment. While taking this medication, regular meals and exercise should be continued, and blood sugar and kidney function should be tested regularly. This medication may interact with other drugs, so it is essential to consult a physician or pharmacist when starting or stopping any new medications. Symptoms of lactic acidosis include difficulty breathing, muscle pain, fatigue, and abdominal pain; if these symptoms appear, notify a physician immediately. Symptoms of hypoglycemia include headache, severe hunger, dizziness, and drowsiness; if these symptoms appear, consume sugar immediately and seek medical help if necessary. This medication requires special caution when administered to children and the elderly, especially in the elderly, kidney function should be checked frequently. In case of overdose, severe hypoglycemia or lactic acidosis may occur, and if suspected, immediate medical attention is required. Be cautious of potential accidents due to hypoglycemia or dizziness when driving or operating machinery. This medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal bloating, loss of appetite, dyspepsia, constipation, abdominal pain, malaise, metallic taste, visual impairment, taste disorder, erythema, itching, urticaria, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, peripheral neuropathy, vitamin B12 deficiency, increased liver enzymes, liver function impairment, bile secretion disorder, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, reduced thyroid-stimulating hormone levels, magnesium deficiency, encephalopathy, hair loss, weight gain, abdominal pain, abdominal bloating, vomiting, dyspepsia, palpitations, dizziness, diarrhea, nausea, leg edema, cardiac arrest, rectal carcinoma, hypoglycemia, headache, severe hunger, fatigue, sleep, weakness, drowsiness, sleep disturbances, instability, aggression, attention deficit, inability to focus, abnormal reflexes, depression, confusion, speech disorder, aphasia, visual disturbances, tremor, paralysis, sensory disturbance, dizziness, inability to self-regulate, delirium, cerebral convulsions, loss of consciousness, coma, weak respiration, slow pulse, sweating, clammy skin, anxiety, rapid pulse, hypertension, palpitations, angina, deep vein thrombosis, stroke, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, at a temperature between 1 and 30 degrees Celsius. Storing this way helps maintain the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

White, rectangular, film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.